Merus NV (MRUS) is around the top of the Biotechnology industry according to InvestorsObserver. MRUS received an overall rating of 62, which means that it scores higher than 62 percent of all stocks. Merus NV also achieved a score of 87 in the Biotechnology industry, putting it above 87 percent of Biotechnology stocks. Biotechnology is ranked 66 out of the 148 industries.
MRUS has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on MRUS!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Merus NV Stock Today?
Merus NV (MRUS) stock is trading at $27.25 as of 11:43 AM on Monday, Apr 11, a decline of -$0.75, or -2.7% from the previous closing price of $28.00. The stock has traded between $27.05 and $27.75 so far today. Volume today is above average. So far 248,618 shares have traded compared to average volume of 139,554 shares.
Click Here to get the full Stock Report for Merus NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
